The Bihormonal iLet Bionic Pancreas Feasibility Study

Clinical trial NCT03840278 · COMPLETED

Trial details

NCT number: NCT03840278
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-05-15
Primary completion: 2019-07-03
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.